These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 32588535)
1. The protective rather than prothrombotic fibrinogen in COVID-19 and other inflammatory states. Thachil J J Thromb Haemost; 2020 Aug; 18(8):1849-1852. PubMed ID: 32588535 [TBL] [Abstract][Full Text] [Related]
2. Coronavirus Disease 2019 Coagulopathy: Disseminated Intravascular Coagulation and Thrombotic Microangiopathy-Either, Neither, or Both. Levi M; Thachil J Semin Thromb Hemost; 2020 Oct; 46(7):781-784. PubMed ID: 32512589 [No Abstract] [Full Text] [Related]
4. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation. Miesbach W; Makris M Clin Appl Thromb Hemost; 2020; 26():1076029620938149. PubMed ID: 32677459 [TBL] [Abstract][Full Text] [Related]
5. Patients with Congenital Bleeding Disorders Appear to be Less Severely Affected by SARS-CoV-2: Is Inherited Hypocoagulability Overcoming Acquired Hypercoagulability of Coronavirus Disease 2019 (COVID-19)? Dorgalaleh A; Dabbagh A; Tabibian S; Baghaeipour MR; Jazebi M; Bahraini M; Fazeli S; Rad F; Baghaeipour N Semin Thromb Hemost; 2020 Oct; 46(7):853-855. PubMed ID: 32557449 [No Abstract] [Full Text] [Related]
6. Circulating Plasminogen Concentration at Admission in Patients with Coronavirus Disease 2019 (COVID-19). Henry BM; Benoit SW; Hoehn J; Lippi G; Favaloro EJ; Benoit JL Semin Thromb Hemost; 2020 Oct; 46(7):859-862. PubMed ID: 32882718 [No Abstract] [Full Text] [Related]
7. Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad. Ahmed S; Zimba O; Gasparyan AY Clin Rheumatol; 2020 Sep; 39(9):2529-2543. PubMed ID: 32654082 [TBL] [Abstract][Full Text] [Related]
8. COVID-19 coagulopathy vs disseminated intravascular coagulation. Levi M Blood Adv; 2020 Jun; 4(12):2850. PubMed ID: 32574369 [No Abstract] [Full Text] [Related]
9. Correlation of indirect markers of hypercoagulability with thromboelastography in severe coronavirus 2019. Hightower S; Ellis H; Collen J; Ellis J; Grasso I; Roswarski J; Cap AP; Chung K; Prescher L; Kavanaugh M; Brown T; Nau M; Clark P Thromb Res; 2020 Nov; 195():69-71. PubMed ID: 32659463 [No Abstract] [Full Text] [Related]
10. Platelet functions and activities as potential hematologic parameters related to Coronavirus Disease 2019 (Covid-19). Salamanna F; Maglio M; Landini MP; Fini M Platelets; 2020 Jul; 31(5):627-632. PubMed ID: 32397915 [TBL] [Abstract][Full Text] [Related]
11. COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure. Spiezia L; Boscolo A; Poletto F; Cerruti L; Tiberio I; Campello E; Navalesi P; Simioni P Thromb Haemost; 2020 Jun; 120(6):998-1000. PubMed ID: 32316063 [TBL] [Abstract][Full Text] [Related]
12. Research in brief: Coagulopathy in COVID-19: Determining and managing thrombotic risk in COVID-19 infection. Pooni RS Clin Med (Lond); 2020 Jul; 20(4):e59. PubMed ID: 32675158 [No Abstract] [Full Text] [Related]
13. Critically ill COVID-19 infected patients exhibit increased clot waveform analysis parameters consistent with hypercoagulability. Tan CW; Low JGH; Wong WH; Chua YY; Goh SL; Ng HJ Am J Hematol; 2020 Jul; 95(7):E156-E158. PubMed ID: 32267008 [No Abstract] [Full Text] [Related]